Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

NCT00006017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: becatecarin

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]